OCUGEN, INC. Investment Income, Interest
OCUGEN, INC. (OCGN) reported Investment Income, Interest of $395.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- OCUGEN, INC. investment income, interest for the quarter ending 2026-06-30 was $395.00K, a 74.01% increase year-over-year.
- OCUGEN, INC. investment income, interest for the quarter ending 2026-03-31 was $132.00K, a 61.52% decline year-over-year.
- OCUGEN, INC. investment income, interest for the quarter ending 2025-12-31 was $144.00K, a 64.71% decline year-over-year.
- OCUGEN, INC. investment income, interest for the quarter ending 2025-09-30 was $207.00K, a 33.23% decline year-over-year.
- OCUGEN, INC. investment income, interest for fiscal 2025 was $922.00K, a 26.30% decline from fiscal 2024.
- OCUGEN, INC. investment income, interest for fiscal 2024 was $1.25M.
- OCUGEN, INC. investment income, interest for fiscal 2020 was $1.06K, a 12.27% decline from fiscal 2019.
- OCUGEN, INC. investment income, interest for fiscal 2019 was $1.21K, a 93.68% decline from fiscal 2018.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $395.00K 10-Q · filed 2026-08-06 | $526.00K 10-Q · filed 2026-08-06 | $671.00K derived: sum of 3 quarters · filed 2026-08-06 | $878.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $132.00K 10-Q · filed 2026-05-08 | $276.00K derived: sum of 2 quarters · filed 2026-05-08 | $483.00K derived: sum of 3 quarters · filed 2026-05-08 | $710.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $351.00K derived: sum of 2 quarters · filed 2026-03-04 | $578.00K derived: sum of 3 quarters · filed 2026-08-06 | $922.00K 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $207.00K 10-Q · filed 2025-11-05 | $434.00K derived: sum of 2 quarters · filed 2026-08-06 | $778.00K 10-Q · filed 2025-11-05 | $1.19M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $227.00K 10-Q · filed 2026-08-06 | $200.00K 10-Q · filed 2025-08-04 | $571.00K 10-Q · filed 2026-08-06 | $600.00K 10-Q · filed 2025-08-04 | $978.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.29M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $343.00K 10-Q · filed 2026-05-08 | $300.00K 10-Q · filed 2025-05-09 | $751.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.06M derived: sum of 3 quarters · filed 2026-05-08 | $1.26M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $718.00K derived: sum of 2 quarters · filed 2026-03-04 | $918.00K derived: sum of 3 quarters · filed 2026-03-04 | $1.25M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $310.00K 10-Q · filed 2025-11-05 | $510.00K derived: sum of 2 quarters · filed 2025-11-05 | $843.00K 10-Q · filed 2025-11-05 | ||||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-04 | $500.00K 10-Q · filed 2025-08-04 | |||||
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-09 | ||||||
| 2021-09-30 | $5.00K 10-Q · filed 2021-11-09 | $15.00K derived: sum of 2 quarters · filed 2021-11-09 | $15.00K 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | $10.00K 10-Q · filed 2021-08-06 | $10.00K 10-Q · filed 2021-08-06 | |||||
| 2020-12-31 | $1.06K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $1.06K derived: sum of 2 quarters · filed 2021-11-09 | $1.06K derived: sum of 3 quarters · filed 2021-11-09 | $1.06K 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $42.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $594.00 10-Q · filed 2020-11-06 | $226.00 derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | $433.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2021-08-06 | $552.00 10-Q · filed 2020-08-14 | $226.00 derived: sum of 3 quarters · filed 2021-08-06 | $362.00 derived: sum of 4 quarters · filed 2021-08-06 | |
| 2020-03-31 | $119.00 10-Q · filed 2020-05-08 | $226.00 derived: sum of 2 quarters · filed 2021-03-19 | $362.00 derived: sum of 3 quarters · filed 2021-03-19 | $739.00 derived: sum of 4 quarters · filed 2021-03-19 | |||
| 2019-12-31 | $107.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $243.00 derived: sum of 2 quarters · filed 2021-03-19 | $620.00 derived: sum of 3 quarters · filed 2021-03-19 | $1.21K 10-K · filed 2021-03-19 | |||
| 2019-09-30 | $136.00 10-Q · filed 2020-11-06 | $513.00 derived: sum of 2 quarters · filed 2020-11-06 | $1.11K 10-Q · filed 2020-11-06 | $2.93K derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $377.00 10-Q · filed 2020-08-14 | $971.00 10-Q · filed 2020-08-14 | $2.79K derived: sum of 3 quarters · filed 2020-08-14 | $6.55K derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $594.00 10-Q · filed 2020-05-08 | $2.41K derived: sum of 2 quarters · filed 2020-05-08 | $6.18K derived: sum of 3 quarters · filed 2020-05-08 | $12.38K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $5.58K derived: sum of 2 quarters · filed 2020-03-27 | $11.78K derived: sum of 3 quarters · filed 2020-03-27 | $19.21K 10-K · filed 2020-03-27 | |||
| 2018-09-30 | $3.76K 10-Q · filed 2019-11-12 | $9.96K derived: sum of 2 quarters · filed 2019-11-12 | $17.39K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $6.20K 8-K/A · filed 2019-10-07 | $13.63K 8-K/A · filed 2019-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |